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Abstract 
Background: Neonatal sepsis is a clinical syndrome followed by bacteraemia in the first month of life and appears to be one of 
the primary causes of mortality and morbidity worldwide. The study aim was to detect the levels of resistin, IL-6, CRP and hs-
CRP in clinically suspected cases of neonatal sepsis and establish its association with the pathogenesis of the disease. Materials 
& Methods: The case control study consists of 78 neonates of whom 42 were clinically suspected case of sepsis admitted in 
NICU of Paediatric department and were taken as cases and 36 were normal healthy neonates taken as control subjects in a 
tertiary care teaching hospital, Durgapur, West Bengal. The cases as well as controls were within 28 days of age. Preterm and 
term neonates (< 28 days of age) of both sexes showing signs of both early and late onset sepsis and also blood culture positive 
were included in the study. Two ml of blood was collected without anticoagulant and serum was separated by centrifugation at 
3500 rpm for 15-20 mins and was used for measurement of hs-CRP, resistin and IL 6. Serum hs-CRP levels was determined with 
a high-sensitivity nephelometric method while the serum level of IL-6 and Resistin were measured by immunoassay Kits 
(Raybiotech, USA). Results: Serum resistin levels were increased in sepsis cases as compared to controls and were statistically 
significant (38.96 ± 17.15 vs 15.49 ± 8.54 ng/ml; p < 0.0001). It was also observed that serum IL 6 levels were higher in sepsis 
cases as compared to controls which was statistically significant (58.19 ± 39.97 versus 8.48 ± 3.90 pg/ml; P < 0.0001). However, 
a weak positive correlation was observed between serum resistin with serum IL 6 level (r = 0.343; P = 0.025) among neonatal 
sepsis subjects while no correlation was seen in controls (r = 0.141; P = 0.411). Conclusion: The measurement of these sepsis 
markers is extremely important only in case of neonates with unclear infectious status. We have observed a significant rise in 
Resistin or IL 6 or hs-CRP which may be suggested as specific marker for the identification of neonatal sepsis.  The combination 
of Resistin or IL 6 or CRP or hs-CRP could therefore be crucial for the diagnosis and would be better predictors of neonatal 
sepsis and may be crucial in the pathogenesis of the disease. 
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Introduction  
Neonatal sepsis is a clinical syndrome followed by 
bacteraemia in the first month of life and appears to be 
one of the primary causes of mortality and morbidity 
worldwide [1]. The death caused is approximately one 
million per year in the neonatal period (0-28 days) 
which are due to infection, and accounts for over 25% 
of global neonatal deaths and 10% of all mortality in 
infants [2]. The prognosis of neonatal sepsis depends 
on early diagnosis and efficient antibiotic therapy [3]. 
The early diagnosis of neonatal sepsis is uncertain 
because of its non-specific clinical presentation and its 
interference with non-infectious conditions like 
respiratory distress syndrome or maladaptation [1,4]. 
Blood culture is gold standard for the diagnosis of 
neonatal sepsis but it has limited sensitivity and also 
time consuming method [5]. Early detection of 
neonatal sepsis reduces the inadvertent use of 
antibiotics, the cost of treatment and also prevents the 
emergence of drug resistant strains. During recent days 
acute phase proteins, pro-inflammatory cytokines, 
adhesion molecules, cell surface markers and 
chemokines are being established to diagnose neonatal 
sepsis such as tumour necrosis factor- alpha (TNF-
alpha), Interleukin-6 (IL-6), Interleukin-8 (IL-8), C-
Reactive protein (CRP), and pro-calcitonin (PCT) has 
been of great interest in potential diagnostic value to 
detect the progression of the disease [6]. Resistin is a 
newly discovered proinflammatory hormone which has 
potential role in adipogenesis and development of 
insulin resistance secreted by adipocytes in mice and 
mononuclear cells or macrophage or neutrophils in 
humans [7, 8]. Few studies showed the role of this 
hormone in inflammation as well as proinflammatory 
agent. C - reactive protein (CRP) is an acute phase 
reactant, produced in the liver bears a half –life of 24 to 
48 hours. It is a commonly used marker to diagnose 
neonatal sepsis but as it takes long time approx 10 to 
12 hours responding to an infection, it is not reliable 
[4]. Further, Interleukin 6 (IL 6), a chemokine 
produced by the T and B lymphocytes is more sensitive 
than CRP, but it has limitations to be used as a sole 
marker of sepsis, as it has a short half life [4]. Highly 
sensitive CRP (hs-CRP) is more sensitive than the 
conventional CRP, hs-CRP assays measures the CRP 
levels lower than that measured by the conventional 
CRP assays. When measured with a high sensitivity 
analytic method, CRP can be used as a diagnostic 
marker of neonatal infection. This is since newborns 
produces insufficient amounts of acute-phase proteins 
and thus respond to infection with a smaller increase in 
CRP compared to adults [9]. Few studies have shown 
the role of resistin, IL6, CRP and hs-CRP for neonatal 
but none of them can consistently diagnose sepsis [1]. 
The association between these markers for the 
prognosis of neonatal sepsis is extremely important to 
diagnose the disease at early stage. In this study, levels 
of Resistin, Interleukin-6 (IL-6), C- reactive protein 
(CRP) and highly sensitive C- reactive protein (hs-
CRP) have been estimated in neonates less than 28-
day-old as potential early neonatal sepsis markers. The 
study was aim to detect the levels of Resistin, IL-6, 
CRP and hs-CRP in clinically suspected cases of 
neonatal sepsis and establish its association with the 
pathogenesis of the disease. 
 
Materials & methods 
 
The case control study consists of 78 neonates of 
whom 42 were clinically suspected case of sepsis 
admitted in NICU of Paediatric department and were 
taken as cases and 36 were normal healthy neonates 
taken as control subjects in a tertiary care teaching 
hospital, Durgapur, West Bengal between July 2018 to 
Decemeber 2018. The cases as well as controls were 
within 28 days of age. Preterm and term neonates (< 28 
days of age) of both sexes showing signs of both early 
and late onset sepsis and also blood culture positive 
were included in the study. The clinical signs and 
symptoms of sepsis includes abdominal distension, 
temperature instability, dyspnoea, tachypnoea 
(>70/min), feeding intolerance, hepatosplenomegaly, 
irritability, tachycardia (HR>190bpmin), bradycardia 
(HR<90bpmin). Neonates born with congenital 
anomalies, type 1 diabetes or those neonates who have 
undergone any surgical procedure were excluded from 
the study. Routine biochemical parameters were done 
for both cases as well as controls. Informed consent 
was taken by either parents in both the groups. The 
study was approved by the Institution Ethics 
committee. About 4 ml of venous blood was taken by 
arm venous puncture in sterile vials. Two ml of blood 
was collected without anticoagulant and serum was 
separated by centrifugation at 3500 rpm for 15 - 20 
mins and was used for measurement of hs-CRP, 
Resistin and IL 6. Serum hs-CRP levels was 
determined with a high-sensitivity nephelometric 
method while the serum level of IL 6 and Resistin were 
measured by immunoassay Kits (Raybiotech, USA). 
For the detection of CRP in serum, CRP kit was used 
which is a rapid latex agglutination test. 0.5-1 ml of 
blood was injected into the Bactec culture vial under 
complete aseptic conditions. Positive vials were Gram 
stained and sub cultured and incubated in appropriate 
temperature and atmospheres according to established 
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methods. Full identification of organisms was done 
with standard bacteriological and biochemical 
methods. Statistical analysis of different biochemical 
parameters was performed by Students' t-test. All 
variables were expressed as mean ± SD (standard 
deviation). Means obtained from two normally 
distributed sample groups were compared by Student's 
unpaired two-tailed “t”-test and for nonparametric 
Mann-Whitney U “t” test. To find out the correlation 
between two variables, Pearson's product moment 
correlation coefficient was used. A value of P < 0.05 
was considered as statistically significant. All statistical 
analyses were performed by using Graph Pad prism 
software (version 5, 2007, San Diego, California, 
USA). 
 Results 
 
The demographic and biochemical profile of the sepsis 
subjects and healthy controls is presented in Table 1. 
There was no significant difference in age, sex 
distribution or BMI in either of the two groups between 
sepsis cases and control subjects (Table 1). All the 
neonatal subjects included in the study were blood 
culture positive. hs-CRP levels were elevated in sepsis 
cases as compared to controls which were found 
statistically significant (Table 1). CRP positive cases 
were seen in sepsis neonates as depicted in Table 2. 
Serum resistin levels were increased in sepsis cases as 
compared to controls and were statistically significant 
(38.96 ± 17.15 vs 15.49 ± 8.54 ng/ml; p < 0.0001) 
(Figure 1A). It was also observed that serum IL 6 
levels were higher in sepsis cases as compared to 
controls which was statistically significant (58.19 ± 
39.97 versus 8.48 ± 3.90 pg/ml; P < 0.0001) (Figure 
1B). However, a weak positive correlation was 
observed between serum resistin with serum IL 6 level 
(r = 0.343; P = 0.025) among neonatal sepsis subjects 
while no correlation was seen in controls (r = 
0.141; P = 0.411) [Figure 2].  
 Discussion 
Neonatal sepsis is an obvious cause of death in 
neonates owing to late onset of symptoms and non-
specific clinical presentation [10]. The blood culture is 
the gold standard for the diagnosis though it is time 
consuming and might be negative due to inadequate 
sample collection or administration of antibiotics intra-
partum or intermittent [5]. However, in this study we 
have taken only the blood culture positive neonates to 
study serum resistin, IL-6 and frequently used acute 
phase reactant CRP or hs-CRP. These markers were 
assessed to find an association out which of the above 
markers alone or in combination would be dependable 
and a better predictor of neonatal sepsis. The markers 
showed statistically significant difference between the 
cases and control groups. The most common organisms 
isolated were Klebsiella species and Coagulase 
negative staphylococcus (CONS) in most of the 
neonates. Few studies also observed that Klebsiella and 
CONS species were the most common organisms in 
case of late-onset neonatal sepsis and its association 
with the biofilm forming strains inhibits the host 
immune system in counteracting the infection which 
gives strength to our results and supports the fact [11]. 
Our study reveals that the serum resistin levels was 
found to be higher in neonatal sepsis which was 
statistically significant with the control group (Figure 
1A). Further a weak correlation was observed between 
serum resistin and serum IL 6 levels in neonatal sepsis 
which was statistically significant (Figure 2). This 
suggests that the proinflammatory protein has a 
potential role in acute as well as chronic inflammation. 
Further, it may be suggested that the activation of 
inflammatory cascade triggered by cytokines and 
characterised by the influx of neutrophils and myriad 
of IL 6 trans-signalling play an important role in the 
pathogenesis of neonatal sepsis [12-15]. Moreover, IL-
6 increases the production of CRP by the liver and 
resistin expression on peripheral blood mononuclear 
cells [16]. One study depicted resistin as an effective 
biomarker in adults with sepsis and resistin levels were 
elevated in inflammatory bowel disease which was in 
correlation with TLC levels, CRP and disease activity 
[17]. A recent study reported resistin as an indicator of 
neonatal sepsis and further showed that resistin may be 
a biomarker of neonatal sepsis with the same efficacy 
as other markers such as CRP, IL6, and procalcitonin 
[18]. However, another study showed that resistin 
levels were higher in neonates with PPROM than in 
those without PPROM [19]. Furthermore, another 
study reported that the basal serum resistin levels were 
significantly lower than the pretreatment and follow up 
levels in both EOS and LOS groups and was 
significantly correlated with CRP levels in premature 
infants with neonatal sepsis [20]. In our study, the 
serum C-reactive protein (CRP) level was significantly 
elevated in the clinically suspected neonatal sepsis 
groups than the control groups which is consistent with 
fewer studies [4, 21, 22]. Other studies showed that 
CRP has high specificity and is a better indicator of 
severe bacterial infection in neonates which may be 
presumed by our results [10]. Moreover, CRP is the 
most extensively studied and commonly available 
laboratory test used for the prognosis and diagnosis of 
neonatal sepsis [1]. A study depicted that serial CRP 
measurement along with other markers such as 
interleukins advances the diagnostic accuracy of 
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neonatal sepsis [1]. Other studies also confirms that the 
CRP level is a good predictor of severe bacterial 
infection in neonatal sepsis, but the increase in CRP 
level is slightly lower in sepsis due to the hindrance of 
CONS infection which is depicted in our study 
[23].The serum level of highly sensitive C-reactive 
protein (hs-CRP) showed significantly higher in the 
clinically suspected sepsis group than in the control 
group and it is also known that hs-CRP is more 
sensitive than the conventional CRP as it measures 
very low levels of CRP. A study showed the hs-CRP 
level was significantly higher in the sepsis group than 
the control group and intensified that it may be used in 
combination with other sepsis markers like interleukin 
(IL 6) and procalcitonin (PCT) would be a better 
predictor of neonatal sepsis than using it alone [24]. In 
our study hs-CRP was assayed along with IL6 or 
resistin and it shows a marked rise in neonates than in 
control groups and may be of good value than the other 
markers in the diagnosis of neonatal sepsis. Thus, the 
above results obtained from our study suggest that the 
CRP or IL 6 or resitin were better predictors and 
dependable markers of neonatal sepsis.Moreover, our 
study showed the serum level of IL 6 is significantly 
higher in the clinically suspected cases of neonatal 
sepsis group than the normal healthy controls which is 
in confirmation with other studies [6, 10, 25, 26]. A 
study revealed that serum IL 6 level showed a highly 
significant value even in umbilical cord blood in septic 
neonates [27]. Another study also showed similar 
sensitivity in culture positive and clinical sepsis 
neonates [27]. Furthermore, a study reported that the 
serum levels of TNF-α and IL-6 when measured 
together for the diagnosis of neonatal sepsis it would 
provide a good sensitivity and specificity [28]. The 
measurement of these sepsis markers is extremely 
important only in case of neonates with unclear 
infectious status. The diagnosis of neonatal sepsis is 
still a challenge for both the laboratory as well as 
clinicians due to, absence of standardized cut-off 
values for sepsis markers and non-specific clinical 
presentation. Despite these we have observed a 
significant rise in Resistin or IL 6 or hs-CRP which 
may be suggested as specific marker for the 
identification of neonatal sepsis.  The combination of 
Resistin or IL 6 or CRP or hs-CRP could therefore be 
crucial for the diagnosis and would be better predictors 
of neonatal sepsis and may be crucial in the 
pathogenesis of the disease. 
Table 1: Demographic and biochemical profile of the subjects 
 Control (n = 42) Cases (n = 36) 
Gestational Age (weeks) 34.8 ± 2.9 35.4 ± 2.2 
Sex (M/F) 32/10 24/12 
Weight (gm) 2284 ± 926 2392 ± 752 
FPG (mg/dl) 82.23 ± 7.22 84.7 ± 9.36 
ESR (mm/h) 15.2 ± 4.24 84.64 ± 49.44* 
hs-CRP (mg/L) 0.84 ± 0.18 3.26 ± 1.2* 
FPG, fasting plasma glucose; ESR, Erythrocyte sedimentation rate; hs-CRP, highsensitivity- C Reactive Protein. Age, BMI, and 
serum levels of biochemical parameters were expressed as the means ± SD. Statistically significant, * p < 0.001 vs Control. 
Table 2:  Serum CRP levels (mg/liter) of patients with Neonatal Sepsis and Controls 
Groups Control (n = 36) Cases (n = 42) 
No. of Cases positive for CRP Nil 40 
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Fig 1A: Serum resistin levels were increased in sepsis cases as compared to controls and were statistically 
significant (38.96 ± 17.15 vs 15.49 ± 8.54 ng/ml; p < 0.0001). 
Fig 1B: Serum IL 6 levels were higher in sepsis cases as compared to controls which was statistically 
significant (58.19 ± 39.97 versus 8.48 ± 3.90 pg/ml; P < 0.0001). 
 
Fig 2: A weak positive correlation was observed between serum resistin with serum IL 6 level (r = 0.343; P = 
0.025) among neonatal sepsis subjects while no correlation was seen in controls (r = 0.141; P = 0.411) 
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